CLINICAL_TRIALS
trial_result
· 2022-05-16
Clinical Trial Update: Efavirenz in Treating Patients With Metastatic Prostate Cancer [Phase 2]
Summary
Phase 2 trial investigating efavirenz for metastatic prostate cancer has completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Institut Bergonié | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-05-16